Trifecta Capital Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Trifecta Capital Advisors's RGEN Position: Q4 2023 in Review
Trifecta Capital Advisors sold out of Repligen (RGEN) in Q4 2023, closing a stake of 35 shares — an estimated $5.57K sold.
Trifecta Capital Advisors first reported a position in RGEN in Q4 2022 and held it in 4 quarters. The position peaked at $5.93K in Q4 2022. 466 funds tracked by Wall St. Rank hold RGEN as of Q4 2023.
- Trifecta Capital Advisors reported no remaining Repligen position as of Q4 2023 after selling out during the quarter.
- Trifecta Capital Advisors sold 35 Repligen shares in Q4 2023, an estimated $5.57K.
- Trifecta Capital Advisors first reported a position in Repligen in Q4 2022 and held it in 4 quarters.
- Trifecta Capital Advisors's Repligen position peaked at $5.93K in Q4 2022.
- 466 funds tracked by Wall St. Rank held Repligen as of Q4 2023.
Based on Trifecta Capital Advisors's 13F filing for Q4 2023, filed 25 Jan 2024.